RENNIE PEPPERMINT Chewable tablet Ref.[50561] Active ingredients: Calcium carbonate Magnesium carbonate

Source: Health Products Regulatory Authority (IE)  Revision Year: 2022  Publisher: Bayer Limited, 1st Floor, The Grange Offices, The Grange, Brewery Road, Stillorgan, Co. Dublin, A94 H2K7, Ireland

Product name and form

Rennie Peppermint 680mg/80mg Chewable Tablets.

Pharmaceutical Form

Chewable Tablet (Tablet).

Creamy white square tablets with occasional slight speckling with concave surfaces engraved ‘RENNIE’ on both faces with odour of peppermint.

Qualitative and quantitative composition

Each tablet contains:

Calcium carbonate 680 mg (272 mg elemental calcium)

Heavy Magnesium Carbonate 80 mg (20 mg elemental magnesium)

Excipients with known effect: Each chewable tablet also contains 250mg Sucrose and 250mg Glucose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Calcium carbonate

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.

Magnesium carbonate

Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3ยท2 H2O), nesquehonite (MgCO3ยท3 H2O), and lansfordite (MgCO3ยท5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining.

List of Excipients

Sucrose
Glucose
Talc
Povidone
Peppermint flavour*
Magnesium stearate
Saccharin sodium

* (mint essential oil, maltodextrin, silicon dioxide (E551), arabic gum)

Pack sizes and marketing

The tablets are packed into PVC/aluminium blisters which are then placed in cardboard cartons to contain 12, 24, 36, 48, 72 or 96 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Bayer Limited, 1st Floor, The Grange Offices, The Grange, Brewery Road, Stillorgan, Co. Dublin, A94 H2K7, Ireland

Marketing authorization dates and numbers

PA1410/053/001

Date of first authorisation: 01 April 1983
Date of last renewal: 01 April 2008

Drugs

Drug Countries
RENNIE Estonia, Spain, Finland, France, Ireland, Israel, Lithuania, Malta, Netherlands, Romania, Singapore, Turkey, South Africa

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.